San Francisco, CA, United States of America

Scott Stawicki

USPTO Granted Patents = 8 


Average Co-Inventor Count = 6.3

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • San Francisco, CA (US) (2010 - 2018)
  • South San Francisco, CA (US) (2018 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations of Scott Stawicki

Introduction

Scott Stawicki is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antibodies. With a total of 8 patents to his name, Stawicki's work has the potential to impact various therapeutic applications.

Latest Patents

Stawicki's latest patents include groundbreaking innovations such as a host cell comprising nucleic acids encoding bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1. This patent provides antibodies that bind to KLB and FGFR1, along with methods of using these antibodies. In certain embodiments, the disclosed bispecific antibody binds to an epitope present on FGFR1 and another epitope present on KLB. Another notable patent focuses on nucleic acids encoding bispecific antibodies binding to beta-Klotho and fibroblast growth factor receptor 1, further emphasizing the importance of his research in this area.

Career Highlights

Scott Stawicki is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry, contributing to advancements in medical science.

Collaborations

Some of Stawicki's notable coworkers include Yan Wu and Yongmei Chen. Their collaborative efforts have further enhanced the research and development of innovative therapies.

Conclusion

Scott Stawicki's contributions to biotechnology through his patents and work at Genentech, Inc. highlight his role as a key innovator in the field. His research on bispecific antibodies has the potential to lead to significant advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…